A Geriatric Mobile Team for Nursing Home Residents: a Feasibility Pilot Study (GerMoT)
A Geriatric Mobile Team for Nursing Home Residents: an Exploratory, Prospective, Single-Center, Non-Randomized, Non-Interventional Feasibility Pilot Study
Nursing home (NH) residents have complex healthcare needs. Barriers to collaboration hinder the delivery of high-quality care in nursing homes. To bridge the gap between hospital-based and NH-based care, various innovative approaches have been proposed, including geriatric mobile teams. In Belgium, geriatric expertise has long been confined to hospital settings. Until recently, no specific organization existed for outpatient geriatric assessment, particularly for NH residents. In April 2024, the National Institute for Health and Disability Insurance (INAMI) introduced a new reimbursement code for geriatric consultations in NHs, promoting the development of extramural geriatric activities. However, evidence on the effectiveness of mobile geriatric teams remains limited, particularly regarding hospitalization prevention.
The geriatrics department of CHU UCL Namur is implementing a one-year pilot project involving a mobile team composed of a geriatrician and a nurse to conduct geriatric assessments in the three nursing homes. This non-randomized pilot project aims to establish a new standard of care for residents selected by their general practitioner, leveraging the new reimbursement code. The project is accompanied by a clinical study assessing the feasibility, effectiveness, and acceptability of this intervention. Prospectively collected data will also help define key indicators for a future large-scale study focused on cost-effectiveness.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Marie de Saint-Hubert
- Phone Number: +3281424027
- Email: marie.desainthubert@chuuclnamur.uclouvain.be
Study Locations
-
-
-
Yvoir, Belgium, 5530
- Chu Ucl Namur
-
Contact:
- Julie Merche
- Phone Number: +3281422175
- Email: julie.merche@chuuclnamur.uclouvain.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged over 70 years
Presenting with one or more of the following conditions:
- Difficulties in establishing an advance care planning
- Medical complexity (multiple specialists, repeated hospitalizations)
- Polypharmacy
- Recurrent falls
- Unmanageable behavioral disorders
- Weight loss
- Memory impairment
Exclusion Criteria:
- Patients with an unstable medical condition requiring urgent care
- Patients under 70 years old
- Patients whose condition requires examinations or treatments available only in a hospital setting
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Experimental group
Nursing home resident with a geriatric consultation at her place of residence
|
The tertiary hospital's geriatrics department is implementing a one-year mobile team composed of a geriatrician and a nurse to conduct geriatric assessments (Anamnesis and heteroanamnesis - Clinical examination - Medication review - Proposed management plan provided to the general practionner, who independently decides which recommendations to implement) in three nursing homes.
This non-randomized pilot project aims to establish a new standard of care for residents selected by their primary care physician.
The project is accompanied by a clinical study designed to assess the feasibility, effectiveness, and acceptability of this intervention.
Prospectively collected data will also help define key indicators for a future large-scale study focusing on cost-effectiveness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Feasability
Time Frame: Immediately after the initial consultation, with follow-up assessments at 3, 6, 9, and up to 12 months post-inclusion.
|
Immediately after the initial consultation, with follow-up assessments at 3, 6, 9, and up to 12 months post-inclusion.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Acceptability
Time Frame: Immediately after the initial consultation, with follow-up assessments at 3, 6, 9, and up to 12 months post-inclusion
|
Immediately after the initial consultation, with follow-up assessments at 3, 6, 9, and up to 12 months post-inclusion
|
|
Determine the outcomes for a future full evaluation study.
Time Frame: Immediately after the initial consultation, with follow-up assessments at 3, 6, 9, and up to 12 months post-inclusion
|
Immediately after the initial consultation, with follow-up assessments at 3, 6, 9, and up to 12 months post-inclusion
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- GerMoT
- 40025834 (Other Identifier: Fond National de la Recherche)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.